Advertisements



LSE Chief Sees IPO Growth

The London Stock Exchange Group’s CEO said the European economy was moving into a “sweet spot” that would encourage more companies to launch initial public offerings......»»

Category: earningsSource: wsj18 hr. 39 min. ago

Horizon Pharma files to sell $300M in exchangeable senior notes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallMar 4th, 2015

Can the Rally in Horizon Pharma (HZNP) Shares Continue? - Tale of the Tape

Can the Rally in Horizon Pharma (HZNP) Shares Continue? Horizon Pharma plc (HZNP) has been on the move lately as the stock has risen by 30.2% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty sol.....»»

Category: topSource: zacksMar 4th, 2015

Can the Rally in Horizon Pharma (HZNP) Shares Continue? - Tale of the Tape

Zacks.....»»

Category: topSource: redinewsMar 4th, 2015

Horizon Pharma Is Still A Strong Buy

Horizon Pharma Is Still A Strong Buy.....»»

Category: topSource: seekingalphaMar 3rd, 2015

MannKind Rating, Price Target Are Cut by Goldman on Slow Afrezza Launch

NEW YORK (TheStreet) -- MannKind was downgraded to a "sell" rating from "neutral" by Goldman Sachs on Tuesday, with the analyst citing the slow commercial launch of the inhaled insulin Afrezza coupled with growing downward pricing pressure for all diab.....»»

Category: topSource: thestreetMar 3rd, 2015

Council vote could open door to expanded Paine Field service - Washington Times

Council vote could open door to expanded Paine Field serviceWashington TimesEVERETT, Wash. (AP) - A Snohomish County Council vote could be an initial step toward commercial air service at the Paine Field airport. On Monday, the council voted 3-2 to approv.....»»

Category: topSource: googlenewsMar 3rd, 2015

Horizon Pharma Beats on Q4 Earnings, Lifts 2015 Guidance - Analyst Blog

Zacks.....»»

Category: topSource: redinewsMar 2nd, 2015

Horizon Pharma Beats on Q4 Earnings, Lifts 2015 Guidance - Analyst Blog

Horizon Pharma's (HZNP) adjusted earnings in the fourth quarter came in at 25 cents per share, above the Zacks Consensus Estimate of 23 cents. Horizon Pharma’s HZNP adjusted earnings (including share-based compensation expenses) in the fo.....»»

Category: topSource: zacksMar 2nd, 2015

Horizon Pharma price target raised to $27 from $18 at Brean Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallMar 2nd, 2015

Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP): Deerfield Management Keeps Betting on Pharmaceuticals and Biotech

James E. Flynn‘s Deerfield Mangement is one of the funds that is focused on the healthcare sector and invests around 70% of its portfolio in healthcare stocks. Among other things, Deerfield specializes in R&D, hostile takeovers and financial advisor.....»»

Category: topSource: insidermonkeyFeb 28th, 2015

Horizon Pharma price target raised to $30 from $24 at Avondale

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallFeb 27th, 2015

Horizon Pharma"s (HZNP) CEO Timothy Walbert on Q4 2014 Results - Earnings Call Transcript

Horizon Pharma"s (HZNP) CEO Timothy Walbert on Q4 2014 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaFeb 27th, 2015

Horizon Pharma (HZNP) Stock Spikes Today on Raised Guidance Despite Quarterly Earnings Loss

NEW YORK (TheStreet) -- Horizon Pharma shares are up 9.95% to $20.97 in early market trading on Friday after the biopharmaceutical company reported its fourth quarter earnings results before the opening bell today. The Dublin, Ireland-based compa.....»»

Category: topSource: thestreetFeb 27th, 2015

Friday"s #PreMarket Movers: JC Penney Down Following Q4 Earnings

Horizon Pharma PLC (NASDAQ: HZNP) +5.5% - Reported Q4 EPS. Weight Watchers International (NYSE: WTW) -15% - Announced Q4 EPS, outlook. JC Penney Co Inc (NYSE: JCP) -11% - Reported Q4 EPS......»»

Category: blogSource: benzingaFeb 27th, 2015

Horizon Pharma (HZNP) Q4 2014 Results - Earnings Call Webcast

Horizon Pharma (HZNP) Q4 2014 Results - Earnings Call Webcast.....»»

Category: topSource: seekingalphaFeb 27th, 2015

Horizon Pharma raises FY15 revenue guidance to $450M-$475M from $425M-$450M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallFeb 27th, 2015

Horizon Pharma reports Q4 adjusted EPS 27c, consensus 22c

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallFeb 27th, 2015

US, Cuba seek breakthrough in new round of historic talks

Washington (AFP) - US and Cuban negotiators launch a second round of historic talks on Friday aimed at overcoming half a century of enmity and restoring full diplomatic ties.After an initial meeting in Havana in January which ended with little apparent br.....»»

Category: topSource: businessinsiderFeb 27th, 2015

Sunovion begins late-stage trials of COPD drug to rival Spiriva

Marlborough-based Sunovion Pharmaceuticals has begun a late-stage trial of a potential inhaled drug to treat chronic obstructive pulmonary disease, or COPD. In a statement, Sunovion, a subsidiary of Sumitomo Dainippon Pharma Co. in Japan, said the three .....»»

Category: topSource: bizjournalsFeb 25th, 2015